Cargando…
In Vivo Delivery of Gremlin siRNA Plasmid Reveals Therapeutic Potential against Diabetic Nephropathy by Recovering Bone Morphogenetic Protein-7
Diabetic nephropathy is a complex and poorly understood disease process, and our current treatment options are limited. It remains critical, then, to identify novel therapeutic targets. Recently, a developmental protein and one of the bone morphogenetic protein antagonists, Gremlin, has emerged as a...
Autores principales: | Zhang, Qingxian, Shi, Yonghong, Wada, Jun, Malakauskas, Sandra M., Liu, Maodong, Ren, Yunzhuo, Du, Chunyang, Duan, Huijun, Li, Yingmin, Li, Ying, Zhang, Yanling |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2908623/ https://www.ncbi.nlm.nih.gov/pubmed/20661431 http://dx.doi.org/10.1371/journal.pone.0011709 |
Ejemplares similares
-
CTGF siRNA ameliorates tubular cell apoptosis and tubulointerstitial fibrosis in obstructed mouse kidneys in a Sirt1-independent manner
por: Ren, Yunzhuo, et al.
Publicado: (2015) -
Niche formed by bone morphogenetic protein antagonists gremlin 1 and gremlin 2 in human hair follicles
por: Niiyama, Shiro, et al.
Publicado: (2022) -
Gremlin induces cell proliferation and extra cellular matrix accumulation in mouse mesangial cells exposed to high glucose via the ERK1/2 pathway
por: Huang, Haixia, et al.
Publicado: (2013) -
The bone morphogenetic protein antagonist gremlin 1 is overexpressed in human cancers and interacts with YWHAH protein
por: Namkoong, Hong, et al.
Publicado: (2006) -
Gremlin, a Bone Morphogenetic Protein Antagonist, Is a Crucial Angiogenic Factor in Pituitary Adenoma
por: Koketsu, Kenta, et al.
Publicado: (2015)